Informations:
Erreur:
ID
33164
Description
Regulation of Tissue Lipolysis by Insulin in Type 2 Diabetes; ODM derived from: https://clinicaltrials.gov/show/NCT01680133
Lien
https://clinicaltrials.gov/show/NCT01680133
Mots-clés
Versions (1)
- 30/11/2018 30/11/2018 -
Détendeur de droits
See clinicaltrials.gov
Téléchargé le
30 novembre 2018
DOI
Pour une demande vous connecter.
Licence
Creative Commons BY 4.0
Modèle Commentaires :
Ici, vous pouvez faire des commentaires sur le modèle. À partir des bulles de texte, vous pouvez laisser des commentaires spécifiques sur les groupes Item et les Item.
Groupe Item commentaires pour :
Item commentaires pour :
Vous devez être connecté pour pouvoir télécharger des formulaires. Veuillez vous connecter ou s’inscrire gratuitement.
Eligibility Type 2 Diabetes NCT01680133
Eligibility Type 2 Diabetes NCT01680133
- StudyEvent: Eligibility
Similar models
Eligibility Type 2 Diabetes NCT01680133
- StudyEvent: Eligibility
Name
Type
Description | Question | Decode (Coded Value)
Type de données
Alias
Caucasian
Item
caucasian
boolean
C0043157 (UMLS CUI [1])
Normal blood pressure | Systolic Pressure | Diastolic blood pressure
Item
normal blood pressure (sbp 100-140 mmhg, dbp 60-90 mmhg)
boolean
C2712122 (UMLS CUI [1])
C0871470 (UMLS CUI [2])
C0428883 (UMLS CUI [3])
C0871470 (UMLS CUI [2])
C0428883 (UMLS CUI [3])
Stable body weight
Item
weight stable in last 3 months
boolean
C0517386 (UMLS CUI [1])
Tobacco use
Item
smokers
boolean
C0543414 (UMLS CUI [1])
Physical fitness training With intensity
Item
people with intensive fitness training (e.g. athletes > 3 times/week)
boolean
C1535955 (UMLS CUI [1,1])
C0522510 (UMLS CUI [1,2])
C0522510 (UMLS CUI [1,2])
Cardiovascular Diseases
Item
history of cardiovascular diseases
boolean
C0007222 (UMLS CUI [1])
Blood Coagulation Disorders
Item
bleeding disorders
boolean
C0005779 (UMLS CUI [1])
Pharmaceutical Preparations Interfere with End Point | Pharmaceutical Preparations Interfere with Clinical Trial Hypothesis | Adrenergic beta-1 Receptor Antagonists
Item
use of medication interfering with the study endpoints/hypotheses (e.g. beta-blockers)
boolean
C0013227 (UMLS CUI [1,1])
C0521102 (UMLS CUI [1,2])
C2349179 (UMLS CUI [1,3])
C0013227 (UMLS CUI [2,1])
C0521102 (UMLS CUI [2,2])
C0008976 (UMLS CUI [2,3])
C1512571 (UMLS CUI [2,4])
C0304516 (UMLS CUI [3])
C0521102 (UMLS CUI [1,2])
C2349179 (UMLS CUI [1,3])
C0013227 (UMLS CUI [2,1])
C0521102 (UMLS CUI [2,2])
C0008976 (UMLS CUI [2,3])
C1512571 (UMLS CUI [2,4])
C0304516 (UMLS CUI [3])
Study Protocol Comprehension Unable
Item
not to be able to understand the study information
boolean
C2348563 (UMLS CUI [1,1])
C0162340 (UMLS CUI [1,2])
C1299582 (UMLS CUI [1,3])
C0162340 (UMLS CUI [1,2])
C1299582 (UMLS CUI [1,3])
On special diet | Vegetarian
Item
subjects on a special diet or vegetarian
boolean
C3164710 (UMLS CUI [1])
C0042441 (UMLS CUI [2])
C0042441 (UMLS CUI [2])
Blood Donation
Item
blood donation 2 months prior to the study and during the study
boolean
C0005794 (UMLS CUI [1])
Study Subject Participation Status
Item
participating in an other study
boolean
C2348568 (UMLS CUI [1])